Haochen Zhang

10PUBLICATIONS
116CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPhylogeny and comparative analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Feb 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna

|Feb 06, 2026
Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer.

Jungeui Hong, Zachary A Kohutek, Haochen Zhang

|Jan 22, 2026
Genomic evolution of pancreatic cancer at single-cell resolution.

Haochen Zhang, Palash Sashittal, Elias-Ramzey Karnoub

Pageof 2

Frequent Collaborators

8 joint publications

Christine Iacobuzio-Donahue

6 joint publications

Elias-Ramzey Karnoub

5 joint publications

Shigeaki Umeda

5 joint publications

Eileen O'Reilly